ZIMMER BIOMET HOLDINGS, INC. Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax of $25.90 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax · last filed 2025-02-25
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net investment hedge, gain (loss), reclassification, before tax for the quarter ending 2022-12-31 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net investment hedge, gain (loss), reclassification, before tax for the quarter ending 2022-09-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net investment hedge, gain (loss), reclassification, before tax for the quarter ending 2022-06-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net investment hedge, gain (loss), reclassification, before tax for the quarter ending 2022-03-31 was $25.90M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), net investment hedge, gain (loss), reclassification, before tax for fiscal 2022 was $25.90M.
| Period end | Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax 3 month | Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax 6 month | Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax 9 month | Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $25.90M 10-K · filed 2025-02-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $25.90M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $25.90M 10-Q · filed 2023-08-01 | ||
| 2022-03-31 | $25.90M 10-Q · filed 2023-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |